Crossmark

Advancing therapy for neuroblastoma

Crossref DOI link: https://doi.org/10.1038/s41571-022-00643-z

Published Online: 2022-05-25

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qiu, Bo https://orcid.org/0000-0003-4199-1659
Matthay, Katherine K. https://orcid.org/0000-0002-0146-2499
License Information

Text and Data Mining valid from 2022-05-25

Version of Record valid from 2022-05-25
More Information

Article History

Accepted: 29 April 2022

First Online: 25 May 2022

Competing interests

: K.K.M. is a consultant for Illumina Radiopharmaceuticals. B.Q. declares no competing interests.